1.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ACTG A5264, 1U01AI068636, NCT01352117
|
|
2.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: ACTG A5263, 1U01AI068636, U01CA121947, NCT01435018
|
|
3.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000664131, U01CA121947, AMC-070, NCT01057121
|
|
4.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 120047, 12-C-0047, NCT01495598
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: AAAC2308, NCT00859456
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 090130, 09-C-0130, NCT00923936
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CKS/IND-CX/05, NCT01067690
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: STH15195, 2008-006007-23, NCT01140737
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 19 to 75 Sponsor: Other Protocol IDs: 2010-022898-33, ANRS 154 LENAKAP, NCT01282047
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: C41-10, NCT01296815
|
|
11.
|
Phase: Phase I Type: Diagnostic, Natural history/Epidemiology Status: Active Age: Not specified Sponsor: Other Protocol IDs: 9361700212, NTUH-94M29, NCT00154921
|
|
12.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000659554, U01CA121947, AMC-063, NCT01016730
|
|
13.
|
Phase: No phase specified Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2006-0493, NCT00432471
|
|
14.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository Status: Active Age: 65 and under Sponsor: NCI Protocol IDs: NCI-97-C-0028, 97-C-0028, NCT00556582
|
|
15.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Diagnostic Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000590397, U01CA121947, AMC-058, NCT00695422
|
|
16.
|
Phase: No phase specified Type: Diagnostic, Health services research Status: Active Age: Not specified Sponsor: Other Protocol IDs: PSTIC GENSARC, NCT00847691
|
|
17.
|
Phase: No phase specified Type: Diagnostic Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: J09111, NA_00032681, P01CA015396, NCT00982449
|
|
18.
|
Phase: No phase specified Type: Tissue collection/Repository Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 010038, 01-C-0038, NCT00006518
|
|
19.
|
Phase: No phase specified Type: Natural history/Epidemiology Status: Active Age: 18 to 45 Sponsor: Other Protocol IDs: ICO-FERTI, FERTI, EU-21105, NCT01295463
|
|
20.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis Status: Active Age: Not specified Sponsor: NIAID Protocol IDs: 999907018, 07-CC-N018, NCT00395278
|
|
21.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 110220, 11-C-0220, NCT01419561
|
|
22.
|
Phase: No phase specified Type: Natural history/Epidemiology Status: Active Age: not specified Sponsor: NCI Protocol IDs: 999906194, 06-C-N194, NCT00904579
|